Surprisingly, Lin et al. showed that mice with whole-body PGC-1α ablation are resistant to HFD-induced obesity as well as exhibit increased insulin sensitivity and ameliorated glycemic control as indicated by glucose tolerance test (Lin et al., 2004). Here, PPARGC1A is linked to obesity due to melanocortin 4 receptor deficiency.